However, in non-MetS STEMI patients, MIF levels were slightly elevated in those with developed MACCE vs. MACCE-free patients but did not reach statistical significance (141 ± 71 vs. 111 ± 51 ng/ml, P = 0.061, Figure 2C). Here, MIF is linked to metabolic syndrome.